Absci Stock (NASDAQ:ABSI)
Previous Close
$2.92
52W Range
$2.45 - $6.72
50D Avg
$3.57
200D Avg
$4.16
Market Cap
$343.42M
Avg Vol (3M)
$1.47M
Beta
2.19
Div Yield
-
ABSI Company Profile
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
ABSI Performance
Peer Comparison
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| DTIL | Precision BioSciences, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| INZY | Inozyme Pharma, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| RXRX | Recursion Pharmaceuticals, Inc. |
| AFMD | Affimed N.V. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |